search
Back to results

Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients

Primary Purpose

Non-small Cell Lung Cancer

Status
Unknown status
Phase
Phase 3
Locations
China
Study Type
Interventional
Intervention
Rehabilitation Training
Rehabilitation Education
TCM
placebo
Sponsored by
Shanghai University of Traditional Chinese Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Non-small Cell Lung Cancer

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Pathologically or cytologically confirmed stage Ia-IIIa non small cell lung cancer;
  • Between the ages of 18 to 75 years old;
  • The score of ECOG ≥2 points
  • Without major organ dysfunction: hemoglobin ≥10 g/dL, absolute neutrophil count (ANC) ≥1.5*10^9/L, platelets ≥100 *10^9/L; normal hepatic and renal function

Exclusion Criteria:

  • Indefinite pathological diagnosis;
  • Expected survival time < 6 months
  • Combined with heart, liver, kidney and hematopoietic system and other serious diseases
  • The patient was treated with antibiotics or infected one week before the test;
  • Pregnant or child breast feeding women;
  • Mental or cognitive disorders;

Sites / Locations

  • YueYang Hosptial of Intergrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Rehabilitation training plus TCM

Rehabilitation education plus placebo

Arm Description

Rehabilitation training include aerobic exercise training and Liu Zi Jue lung exercises, which will be started in one month after operation. Prescriptions formulated into granules origin from Professor Xu Ling in Yueyang hospital. Package of granules is made into three types with functions such as benefiting Qi recipe, benefiting Yin recipe and detoxication and resolving masses recipe. Each package contained 20g of water-soluble herbal granules that were manufactured at a Good Manufacture Practice standard facility (Tian Jiang Ltd, Jiangyin, China). Each package was labeled with a serial number. The prescription form comprised the stock list with both the name and serial number.The patient will take TCM granules for 3 months.

Patients who received rehabilitation education will not accept rehabilitation training. We compromise the raw materials for the placebo including food color and artificial flavors. The placebo and therapeutic packages were stored in different cabinets, and only the dispensing technician knew the contents of the packages. The patient will take placebo granules for 3 months.

Outcomes

Primary Outcome Measures

Change from baseline in Quality of life (QOL)
QOL is assessed using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer 43 (EORTC QLQ-LC43).

Secondary Outcome Measures

Residual capacity (RV)
RV is measured in a test known as Lung valume(LV)spirometry,a type of pulmonary function test.RV is the volume of air remaining in the lungs after a maximal expiratory effort.
Total lung capacity(TLC)
TLC is measured in a test known as Lung valume(LV)spirometry,a type of pulmonary function test.TLC equals the vital capacity plus the residual capacity.
Forced vital capacity (FVC)
FVC is the volume of air exhaled with maximum effort and speed after a full inspiration. FVC is measured in a test known as spirometry, a type of pulmonary function test.
Forced expiratory volume in one second(FEV1)
FEV1 is an individual test measure used to assess limitations in airflow, a type of pulmonary function test,which measures the amount of air exhaled in onesecond.
Maximum mid expiratory flow(MMEF)
MMEF is forced expiratory flow between 25% and 75% of forced vital capacity,a type of pulmonary function test.
Disease-free survival (DFS)
Time from randomization to first recurrence or metastasis
TCM symptoms changes
TCM symptoms changes are according to the lung cancer symptom classification quantization table in "Guiding Principles for Clinical Research of Traditional Chinese Medicine in the Treatment of Lung Cancer (2002 Edition)"
Tumor markers
Tumor markers include CEA, CA-125 and CYFRA21-1
Safety assessment evaluated according to Common Toxicity Criteria
Safety assessment is evaluated according to Common Toxicity Criteria (CTC 3.0)

Full Information

First Posted
July 19, 2017
Last Updated
June 11, 2019
Sponsor
Shanghai University of Traditional Chinese Medicine
Collaborators
Shanghai Chest Hospital, Shanghai Pulmonary Hospital, Shanghai, China, Shanghai Cancer Hospital, China, Huadong Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03244605
Brief Title
Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients
Official Title
Clinical Study on the Effect of Comprehensive Rehabilitation Program on Quality of Life and Long-term Survival in Postoperative Non Small Cell Lung Cancer Patients
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2016 (Actual)
Primary Completion Date
September 30, 2019 (Anticipated)
Study Completion Date
December 30, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai University of Traditional Chinese Medicine
Collaborators
Shanghai Chest Hospital, Shanghai Pulmonary Hospital, Shanghai, China, Shanghai Cancer Hospital, China, Huadong Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators performed a multi-centered, randomized, placebo-controlled, prospective clinical trial on the effect of comprehensive rehabilitation program to improve quality of life(QOL) and long-term survival of postoperative patients with early lung cancer. The investigators plan to enroll 236 cases in 3 years (118 cases for rehabilitation training plus traditional Chinese medicine (TCM), 118 cases for rehabilitation education plus placebo), expecting that comprehensive rehabilitation program has a better efficacy on improving QOL and long-term survival.
Detailed Description
Non-Small-Cell Lung Cancer(NSCLC)is one of the malignancies with high incidence and mortality. In recent years, surgery become the preferred treatment for early stage of NSCLC. Patients with stage IA-IIIA lung cancer can undergo radical surgery, but postoperative lung cancer patients also have shortness of breath, chest pain, cough, expectoration, upper limb dysfunction and other symptoms. The symptoms seriously affect the quality of life and follow-up treatment. Comprehensive rehabilitation program may alleviate the symptoms as an effective treatment which including rehabilitation training and TCM. The investigators performed a multi-centered, randomized, placebo-controlled, prospective clinical trial on the effect of comprehensive rehabilitation program to improve quality of life(QOL) and long-term survival of postoperative patients who are not recommended for postoperative chemotherapy at stage IA and IB. Patients are randomized into observational group (rehabilitation training plus TCM), and control group (rehabilitation education plus placebo). The treatment should be last three months and the patients will be followed up regularly. The primary efficacy assessments are: (1) QOL (QLQ-LC43 scale); (2) Pulmonary function test(PFTs): 1) Forced vital capacity (FVC); 2) Forced expiratory volume in one second (FEV1); 3) Forced expiratory flow rate from 25% to 50% (FEF25-50); 4) Residual volume (RV); 5) Total lung capacity (TLC). Secondary efficacy assessments are: (1) 2 years disease-free survival; (2) TCM symptoms changes; (3) Tumer markers (CEA, CA-125 and CYFRA21-1); (4) Exercise tolerance; (5) Toxicity, side effects and security of the treatments will be assessed at the same time. The investigators plan to enroll 236 cases in 3 years (118 cases for rehabilitation training plus TCM, 118 cases for rehabilitation education plus placebo), expecting that comprehensive rehabilitation program has a better efficacy on improving QOL and long-term survival.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non-small Cell Lung Cancer

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
236 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Rehabilitation training plus TCM
Arm Type
Experimental
Arm Description
Rehabilitation training include aerobic exercise training and Liu Zi Jue lung exercises, which will be started in one month after operation. Prescriptions formulated into granules origin from Professor Xu Ling in Yueyang hospital. Package of granules is made into three types with functions such as benefiting Qi recipe, benefiting Yin recipe and detoxication and resolving masses recipe. Each package contained 20g of water-soluble herbal granules that were manufactured at a Good Manufacture Practice standard facility (Tian Jiang Ltd, Jiangyin, China). Each package was labeled with a serial number. The prescription form comprised the stock list with both the name and serial number.The patient will take TCM granules for 3 months.
Arm Title
Rehabilitation education plus placebo
Arm Type
Placebo Comparator
Arm Description
Patients who received rehabilitation education will not accept rehabilitation training. We compromise the raw materials for the placebo including food color and artificial flavors. The placebo and therapeutic packages were stored in different cabinets, and only the dispensing technician knew the contents of the packages. The patient will take placebo granules for 3 months.
Intervention Type
Other
Intervention Name(s)
Rehabilitation Training
Other Intervention Name(s)
aerobic exercise training, Liu Zi Jue lung exercises
Intervention Description
Patients will be trained in one month after operation. Rehabilitation training include aerobic exercise training (using cycle ergometer for 7-14 times at all, once a day, 15-20 min/time and using treadmill for 7-14 times at all, once a day, 15-20 min/time according to the patient's endurance) and Liu Zi Jue lung exercises, which strengthen the lung function of the human body in Chinese traditional health culture, five times a week, 15 min/time.
Intervention Type
Other
Intervention Name(s)
Rehabilitation Education
Other Intervention Name(s)
health education
Intervention Description
General health education
Intervention Type
Drug
Intervention Name(s)
TCM
Other Intervention Name(s)
Prescriptions from Professor Xu Ling
Intervention Description
three types with functions such as benefiting Qi recipe, benefiting Yin recipe and detoxication and resolving masses recipe.
Intervention Type
Drug
Intervention Name(s)
placebo
Other Intervention Name(s)
control
Intervention Description
three types with functions such as benefiting Qi recipe, benefiting Yin recipe and detoxication and resolving masses recipe,with the same color, smell,taste weight and package
Primary Outcome Measure Information:
Title
Change from baseline in Quality of life (QOL)
Description
QOL is assessed using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer 43 (EORTC QLQ-LC43).
Time Frame
baseline, at 3 months
Secondary Outcome Measure Information:
Title
Residual capacity (RV)
Description
RV is measured in a test known as Lung valume(LV)spirometry,a type of pulmonary function test.RV is the volume of air remaining in the lungs after a maximal expiratory effort.
Time Frame
after intervention at 2 weeks
Title
Total lung capacity(TLC)
Description
TLC is measured in a test known as Lung valume(LV)spirometry,a type of pulmonary function test.TLC equals the vital capacity plus the residual capacity.
Time Frame
after intervention at 2 weeks
Title
Forced vital capacity (FVC)
Description
FVC is the volume of air exhaled with maximum effort and speed after a full inspiration. FVC is measured in a test known as spirometry, a type of pulmonary function test.
Time Frame
after intervention at 2 weeks
Title
Forced expiratory volume in one second(FEV1)
Description
FEV1 is an individual test measure used to assess limitations in airflow, a type of pulmonary function test,which measures the amount of air exhaled in onesecond.
Time Frame
after intervention at 2 weeks
Title
Maximum mid expiratory flow(MMEF)
Description
MMEF is forced expiratory flow between 25% and 75% of forced vital capacity,a type of pulmonary function test.
Time Frame
after intervention at 2 weeks
Title
Disease-free survival (DFS)
Description
Time from randomization to first recurrence or metastasis
Time Frame
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 60 months
Title
TCM symptoms changes
Description
TCM symptoms changes are according to the lung cancer symptom classification quantization table in "Guiding Principles for Clinical Research of Traditional Chinese Medicine in the Treatment of Lung Cancer (2002 Edition)"
Time Frame
after intervention at 3 months
Title
Tumor markers
Description
Tumor markers include CEA, CA-125 and CYFRA21-1
Time Frame
after intervention at 3 months
Title
Safety assessment evaluated according to Common Toxicity Criteria
Description
Safety assessment is evaluated according to Common Toxicity Criteria (CTC 3.0)
Time Frame
after intervention at 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pathologically or cytologically confirmed stage Ia-IIIa non small cell lung cancer; Between the ages of 18 to 75 years old; The score of ECOG ≥2 points Without major organ dysfunction: hemoglobin ≥10 g/dL, absolute neutrophil count (ANC) ≥1.5*10^9/L, platelets ≥100 *10^9/L; normal hepatic and renal function Exclusion Criteria: Indefinite pathological diagnosis; Expected survival time < 6 months Combined with heart, liver, kidney and hematopoietic system and other serious diseases The patient was treated with antibiotics or infected one week before the test; Pregnant or child breast feeding women; Mental or cognitive disorders;
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ling Xu, MD & PhD
Organizational Affiliation
Shanghai University of Traditional Chinese Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
YueYang Hosptial of Intergrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200437
Country
China

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35774470
Citation
Qin X, Bi L, Yang W, He Y, Gu Y, Yang Y, Gong Y, Wang Y, Yan X, Xu L, Xiao H, Jiao L. Dysbiosis of the Gut Microbiome Is Associated With Histopathology of Lung Cancer. Front Microbiol. 2022 Jun 14;13:918823. doi: 10.3389/fmicb.2022.918823. eCollection 2022.
Results Reference
derived

Learn more about this trial

Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients

We'll reach out to this number within 24 hrs